MIC Test Strip. for antimicrobial susceptibility testing

Size: px
Start display at page:

Download "MIC Test Strip. for antimicrobial susceptibility testing"

Transcription

1 for antimicrobial susceptibility testing Liofilchem Liofilchem Quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms and for detecting the resistance mechanisms. are porous strips with special features (International Patent) that are impregnated with a predefined concentration gradient of antibiotic, across 15 two-fold dilutions of a conventional M.I.C. method. On one side of the strip is indicated a M.I.C. scale in μg/ml and a code that identify the antimicrobial agent. For ESBL, MBL, GRD, AmpC and KPC detection, the double-sided gradient carries the appropriate diagnostic reagents. are available in a large variety of configurations. Each configuration is available in packages of 10, 30 and 100 tests. Mixed culture on Chromatic MH Meropenem Staphylococcus aureus ATCC Tigecycline M.I.C. = 0.19 method principle When the is applied onto an inoculated agar surface, the preformed exponential gradient of antimicrobial agent is immediately transferred to the agar matrix. After 18 hours incubation or longer, a symmetrical inhibition ellipse centered along the strip is formed. The MIC is read directly from the scale in terms of at the point where the edge of the inhibition ellipse intersects the strip. Other growth/inhibition patterns may also be seen for resistance detection methods. Staphylococcus aureus Vancomycin / Teicoplanin GRD+ BIBLIOGRAPHY Klebsiella pneumoniae Ertapenem / Ert. +Phenylboronic acid KPC + CLSI M100-S27, Performance Standards for Antimicrobial Susceptibility Testing. CLSI M7-A10, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. CLSI M11-A8 Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. CLSI M11-S1 Performance Standards for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. CLSI M27-A3. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Third Edition. CLSI M27-S4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational supplement. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters Version 7.1, March 2017.

2 for ANTIMICROBIAL susceptibility testing AMIKACIN AK AMOXICILLIN AML AMOXICILLIN*-CLAVULANIC ACID (2/1) CLSI recommended AMOXICILLIN*-CLAVULANIC ACID (2 μg/ml) EUCAST recommended * AUG * AMC AMPICILLIN AMP AMPICILLIN*-SULBACTAM (2/1) CLSI recommended AMPICILLIN*-SULBACTAM (4 μg/ml) EUCAST recommended * AMS * SAM AZITHROMYCIN AZM AZTREONAM ATM AZTREONAM ATM BACITRACIN BA CEFACLOR CEC CEFAZOLIN KZ CEFEPIME FEP CEFIXIME CFM CEFOPERAZONE*-SULBACTAM (2/1) * CPS CEFOTAXIME CTX CEFOTAXIME CTX CEFOTETAN CTT CEFOXITIN FOX CEFPIROME CR CEFPODOXIME PX CEFTAROLINE CPT CEFTAROLINE CPT CEFTAZIDIME (FDA cleared) CAZ CEFTAZIDIME*-AVIBACTAM * CZA CEFTIBUTEN CTB CEFTIZOXIME CZX CEFTOBIPROLE BPR CEFTOLOZANE*-TAZOBACTAM (FDA cleared) * C/T

3 for ANTIMICROBIAL susceptibility testing CEFTRIAXONE CRO CEFTRIAXONE CRO CEFUROXIME CXM CEPHALOTHIN KF CHLORAMPHENICOL C CIPROFLOXACIN CIP CLARITHROMYCIN CLR CLINDAMYCIN (FDA cleared) CD CLOXACILLIN CX COLISTIN CS COLISTIN CS DALBAVANCIN (FDA cleared) DAL DAPTOMYCIN (Includes Ca 2+ ) DAP DELAFLOXACIN (FDA cleared) DLX DORIPENEM DOR DOXYCYCLINE DXT ENROFLOXACIN ENR ERTAPENEM ETP ERYTHROMYCIN (FDA cleared) E FLORFENICOL FFC FOSFOMYCIN (Includes Glucose-6-Phosphate) FOS FOSFOMYCIN (Includes Glucose-6-Phosphate) FOS FUSIDIC ACID FU GATIFLOXACIN GAT GEMIFLOXACIN GEM GENTAMICIN CN GENTAMICIN CN IMIPENEM IMI KANAMYCIN K LEVOFLOXACIN LEV

4 for ANTIMICROBIAL susceptibility testing LINEZOLID LNZ MARBOFLOXACIN MAR MECILLINAM MEC MEROPENEM (FDA cleared) MRP MEROPENEM MRP MEROPENEM*-VABORBACTAM (8 μg/ml) (FDA cleared) * M/V METRONIDAZOLE MTZ MOXIFLOXACIN MXF MUPIROCIN MUP MINOCYCLINE MN NALIDIXIC ACID NA NETILMICIN NET NORFLOXACIN NOR NITROFURANTOIN F OFLOXACIN OFX OXACILLIN OX PENICILLIN G P PENICILLIN G P PIPERACILLIN PIP PIPERACILLIN*-TAZOBACTAM (4 μg/ml) * TZP POLYMYXIN B PB QUINUPRISTIN-DALFOPRISTIN QDA RIFAMPICIN RD RIFAMPICIN RD SPECTINOMYCIN SPC SPIRAMYCIN SP STREPTOMYCIN S SULBACTAM SUL SULFAMETHOXAZOLE SMX TEDIZOLID (FDA cleared) TZD

5 for ANTIMICROBIAL susceptibility testing TEICOPLANIN TEC TELAVANCIN TLV TELAVANCIN (FDA cleared) TLV TEMOCILLIN TMO TETRACYCLINE TE TIAMULIN TIA TICARCILLIN*-CLAVULANIC ACID (2 μg/ml) * TTC TIGECYCLINE TGC TILMICOSIN TIL TOBRAMYCIN TOB TOBRAMYCIN TOB TRIMETHOPRIM TM TRIMETHOPRIM*-SULFAMETHOXAZOLE (1/19) * SXT VANCOMYCIN (FDA cleared) VA for ANTIFUNGAL susceptibility testing AMPHOTERICIN B AMB ANIDULAFUNGIN AND CASPOFUNGIN CAS FLUCONAZOLE FLU FLUCYTOSINE FC ISAVUCONAZOLE IVU ITRACONAZOLE ITC KETOCONAZOLE KE MICAFUNGIN MYC POSACONAZOLE POS VORICONAZOLE VO for KPC detection MEROPENEM / MEROPENEM + PHENYLBORONIC ACID / MRP/MBO ERTAPENEM / ERTAPENEM + PHENYLBORONIC ACID / ETP/EBO

6 ESBL for confirmation of Extended Spectrum Beta-Lactamase CEFEPIME/CEFEPIME+CLAVULANIC ACID (4 μg/ml) / CEFOTAXIME/CEFOTAXIME+CLAVULANIC ACID (4 μg/ml) / CEFTAZIDIME/CEFTAZIDIME+CLAVULANIC ACID (4 μg/ml) / FEP/FEL CTX/CTL CAZ/CAL MBL for detection of Metallo Beta-Lactamase IMIPENEM / IMIPENEM + EDTA / 1-64 IMIPENEM / IMIPENEM + EDTA / MEROPENEM / MEROPENEM + EDTA / IMI/IMD IMI/IMD MRP/MRD GRD for detection of Glycopeptide Resistance VANCOMYCIN / TEICOPLANIN / VA/TEC CTT/CXT ETP/ECX for AmpC detection CEFOTETAN / CEFOTETAN+CLOXACILLIN / ERTAPENEM / ERTAPENEM + CLOXACILLIN / for ANTIMYCOBACTERIAL susceptibility testing MTS Synergy Applicator Platform 1 unit MTS Synergy Delivery Tool 10 disposable applicators ETHAMBUTOL EB ETHIONAMIDE ET ISONIAZIDE IZ MTS Synergy Application System (International Patent) Accessories Rotating Plate Inoculator for confluent microbial growth on the petri dish DEN-1B McFarland densitometer with built-in adapter for 18 mm tubes A-16 Adapter for 16 mm tubes CKG18 calibration kit for DEN-1, for 18mm glass tubes CKG16 calibration kit for DEN-1, for 16mm glass tubes Storage Tube with Desiccant McFarland Standard Set McFarland 1 McFarland 2 McFarland tubes 5 tubes 1 tube 1 tube 1 tube

7 Ready to use culture media DESCRIPTION MUELLER HINTON AGAR II for antimicrobial susceptibility testing of non-fastidious organisms. MUELLER HINTON AGAR II + SHEEP BLOOD 5% for antimicrobial susceptibility testing of fastidious organisms. FORMAT 140 mm 140 mm MUELLER HINTON FASTIDIOUS AGAR (Horse blood 5% + 20 mg/l β-nad) EUCAST recommended: for antimicrobial susceptibility testing of Streptococcus spp., Haemophilus spp., 140 mm and some other fastidious organisms. MUELLER HINTON AGAR II + 2% NaCl for antimicrobial susceptibility testing of staphylococci with Oxacillin. CHROMATIC MH Chromogenic medium for the preliminary identification and susceptibility testing of bacteria directly 140 mm from clinical and environmental specimens. BRUCELLA BLOOD AGAR with HEMIN AND VITAMIN K1 for antimicrobial susceptibility testing of anaerobic bacteria. SCHADLER K AGAR (SHEEP BLOOD 5%) for antimicrobial susceptibility testing of anaerobic bacteria. HAEMOPHILUS TEST AGAR for Haemophilus spp. susceptibility testing. PACKAGING REF MIDDLEBROOK 7H11 AGAR for antimicrobial susceptibility testing of mycobacteria. R.P.M.I. AGAR (2% glucose + MOPS) for antifungal susceptibility testing mm E. coli ATCC SXT M.I.C. = S. pneumoniae ATCC S. aureus ATCC CRO FOX M.I.C. = M.I.C. = 1.5 S. pneumoniae ATCC E M.I.C. = C. krusei ATCC 6258 POS M.I.C. = S. aureus ATCC FU M.I.C. = 0.50 C. krusei VO M.I.C. = 0.25 P. aeruginosa ATCC TZP M.I.C. = 8 S. maltophilia ATCC IMI/IMD 4-256/1-64 E. coli DSM CTX/CTL / MBL+ ESBL+ E. coli CAZ/CAL / ESBL+ K. pneumoniae ATCC BAA-1144 CTT/CXT / AmpC+

8 Contact your local dealer or Liofilchem headquarter for availability. Argentina MedicaTec S.R.L. Tel Fax Denmark Biotech-IgG A/S Tel Fax Malaysia Premier Diagnostics Sdn Bhd Tel Fax Singapore Premier Diagnostics Pte Ltd Tel Fax Australia Integrated Sciences Pty Ltd Tel Fax Estonia Borsa Eesti OÜ Tel Fax borsa@borsa.ee Mexico Abalat, S.A. de C.V. Tel (01 55) Slovakia Bio G spol. s r.o. Tel Fax Austria IVD Uhl-Michelin e.u. Tel.:+43 (0) Fax: +43 (0) werner.uhl-michelin@ivd.at Finland Immuno Diagnostic Oy Tel Fax Netherlands EWC Diagnostics B.V. Tel +31 (0) carin.smale@ewcdiagnostics.com Slovenia Mediline d.o.o. Tel Fax Belarus Multi Lab Ltd. Tel.: Fax: multilab@multilab.by France i2a Tel Fax New Zealand Point View Laboratories Ltd Tel Fax info@pointviewlaboratories.com South Africa Davies Diagnostics (PTY Ltd) Tel Fax Belgium ELITech Group B.V. Tel +32 (0) Fax +32 (0) c.notte@elitechgroup.com Germany bestbion dx GmbH Tel Fax service@bestbion.com Norway Montebello Diagnostics AS Tel Fax Spain Werfen España, SAU Tel Fax Brazil Plast Labor Tel (21) (21) (21) (21) plabor@plastlabor.com.br Greece Varelas S.A. Tel Fax microbiology@varelas.gr Paraguay GT Scientific S.A. Tel Fax ventas@gtscientific.com.py Sweden Biotech-IgG AB Tel Fax ak@biotech-igg.com Bulgaria Elta 90M Tel Fax Hong Kong Bio-Gene Technology Ltd. Tel Fax info@bio-gene.com.hk Poland Argenta Spółka z ograniczoną odpowiedzialnością Sp.k. tel fax argenta@argenta.com.pl Switzerland Apteq AG Tel: Fax: Canada Alere Canada Tel (613) Fax (613) Hungary Frank Diagnosztika Kft. Tel , Fax Portugal Werfen Portugal, LDA Tel Fax product range only Thailand Envimed Co., Ltd. Tel Fax envimed@tru .co.th Chile Medica Tec de Chile S.A. Tel +56 (02) fax +56 (02) mrojas@medica-tec.cl Ireland Launch Diagnostics Ireland Tel Fax desruddy@launchdiagnostics.ie Russia Agros-International, Zao Tel +7 (812) Fax +7 (812) agros@agros-int.com Turkey Kemiteks Kimyevi Mad. Tic. Ltd. Sti. Tel Fax Colombia Annar Diagnóstica Tel Fax ventas@annardx.com Italy Liofilchem Tel Fax Saudi Arabia Gamsco Tel Fax drmalyousef@yahoo.com United Kingdom Launch Diagnostics Ltd Tel +44(0) Fax +44(0) enquiries@launchdiagnostics.com Czech Republic BioVendor Tel Fax Lithuania Biometrija tel fax Serbia Uni-Chem Tel Fax United States Liofilchem, Inc. Waltham, MA tel Liofilchem IVD In USA, available for products noted as "FDA Cleared" in the product list. Via Scozia zona ind.le, Roseto degli Abruzzi (Te) Italy Tel Fax liofilchem@liofilchem.net ref Rev.35 /

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Product Catalogue 2017 Clinical and Industrial Microbiology

Product Catalogue 2017 Clinical and Industrial Microbiology Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

AMR Industry Alliance Antibiotic Discharge Targets

AMR Industry Alliance Antibiotic Discharge Targets AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Product Catalogue 2016 Clinical and Industrial Microbiology

Product Catalogue 2016 Clinical and Industrial Microbiology Antibiotic discs in cartridge Description μg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ... SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

2 New products for 2014

2 New products for 2014 2 New products for 2014 Group B Streptococci Testing Thermo Scientific Brilliance GBS Agar Thermo Scientific TM Brilliance GBS Agar is a clear, selective chromogenic medium for the presumptive identification

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products IVD solutions through partnership MASTDISCS AST Leading the field with a complete solution for AST and Identification disc testing Comprehensive range Premium quality products Compatible with EUCAST and

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

Consumption of antibiotics in hospitals. Antimicrobial stewardship. Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

BSAC standardized disc susceptibility testing method (version 8)

BSAC standardized disc susceptibility testing method (version 8) Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development

More information

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital 2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017)

EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017) EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017) Questions on this document can be directed towards: Karl Mertens Scientific

More information

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS LABORATORIES ON THE FRONT LINE From the National Action Plan for Combating Antibiotic Resistant

More information

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital 2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....

More information

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010

by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and

More information

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints

More information

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics. Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

More information

Liofilchem. ID-AST systems

Liofilchem. ID-AST systems Liofilchem ID-AST systems Systems for ID and AST directly from clinical specimens page 1 Integral Systems for ID and AST from isolated colonies page 4 Systems for ID from isolated colonies page 6 Systems

More information

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

This document is protected by international copyright laws.

This document is protected by international copyright laws. Table 2C Table 2C. and s for Product Name: Infobase 2010 - Release Date: February 2010 60 Clinical and Laboratory Standards Institute. All rights reserved. Testing Conditions Medium: diffusion: MHA Broth

More information

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...

More information

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author EUCAST and susceptibility testing Europe and beyond Gunnar Kahlmeter EUCAST, ESCMID Antimicrobial susceptibility testing To guide therapy and predict clinical outcome in individual patients (clinical breakpoints)

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi

More information

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis Aim: to estimate the burden of MDROs isolated among inpatients in a wide range of health-care

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

Main objectives of the EURL EQAS s

Main objectives of the EURL EQAS s EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)

More information

Including data call, instructions for participating laboratories, data definition, reporting procedure.

Including data call, instructions for participating laboratories, data definition, reporting procedure. EARS-Net Belgium 2016 - Protocol: Including data call, instructions for participating laboratories, data definition, reporting procedure. (version 7, 6/7/2017) Questions on this document can be directed

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial

More information

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

MRSA surveillance 2014: Poultry

MRSA surveillance 2014: Poultry Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity

More information

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system MICRONAUT diagnostics with passion Use the reference method and fill the gap of your fully automated system MICRONAUT systems for the identification and susceptibility testing of bacteria and yeast The

More information

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse

More information

- the details, where possible, of the antibiotic products these companies supply or have supplied.

- the details, where possible, of the antibiotic products these companies supply or have supplied. Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Measuring Antibiotic Use in NHSN

Measuring Antibiotic Use in NHSN Measuring Antibiotic Use in NHSN Jonathan R. Edwards, MStat. Research Mathematical Statistician Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases SHEA

More information

Version 7, January 2008

Version 7, January 2008 BSAC Methods for Antimicrobial Susceptibility Testing Version 7, January 2008 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews@swbh.nhs.uk 1 Contents Page Working Party members

More information

Infectious Disease: Drug Resistance Pattern in New Mexico

Infectious Disease: Drug Resistance Pattern in New Mexico Infectious Disease: Drug Resistance Pattern in New Mexico Are these the world's sexiest accents? Obi C. Okoli, MD.,MPH. Clinic for Infectious Diseases Las Cruces, NM. Are these the world's sexiest accents?

More information

Antimicrobial Susceptibility Patterns

Antimicrobial Susceptibility Patterns Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department

More information

Chapter 2. Disk diffusion method

Chapter 2. Disk diffusion method Chapter 2. Disk diffusion method Tendencia, Eleonor A. Date published: 2004 To cite this document : Tendencia, E. A. (2004). Chapter 2. Disk diffusion method. In Laboratory manual of standardized methods

More information

A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts http://resistancemap.cddep.org A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts CDDEP first developed ResistanceMap in 21. The new ResistanceMap now includes

More information

Available online at ISSN No:

Available online at  ISSN No: Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other

More information

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER. REVOLUTIONARY. Are recurrent bacterial infections a frustration in your practice? WE HAVE FOUND THE ANSWER. MMinimum inimizing BBiofilm EEradication C oncentration Concentration www.becscreen.com WHY BIOFILM

More information

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Penicillins - EUCAST clinical MIC breakpoints (version 1.3) EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae

More information

Summary of the latest data on antibiotic consumption in the European Union

Summary of the latest data on antibiotic consumption in the European Union Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information